Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Expert InterviewsAround the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Treatment Algorithm for Hepatocellular Carcinoma

home / treatment-algorithms-with-the-oncology-brothers / treatment-algorithm-for-hepatocellular-carcinoma

Tanios S. Bekaii-Saab, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss treatment practices for patients with hepatocellular carcinoma.


Tanios S. Bekaii-Saab, MD, and the Oncology Brothers presenting slides

EP. 1: Treating Early- and Intermediate-Stage Hepatocellular Carcinoma

Rahul Gosain, MD;Rohit Gosain, MD;Tanios S. Bekaii-Saab, MD, FACP
April 1st 2024

Tanios S. Bekaii-Saab, MD, joins Rahul Gosain, MD, and Rohit Gosain, MD, to discuss treatment practices for early- and intermediate-stage hepatocellular carcinoma.


Tanios S. Bekaii-Saab, MD, and the Oncology Brothers presenting slides

EP. 2: Localized Therapy in Early- and Intermediate-Stage HCC

Rahul Gosain, MD;Rohit Gosain, MD;Tanios S. Bekaii-Saab, MD, FACP
April 1st 2024

Medical oncologists outline localized therapy options for patients with early- and intermediate-stage hepatocellular carcinoma.


Tanios S. Bekaii-Saab, MD, and the Oncology Brothers presenting slides

EP. 3: First- and Second-Line Treatment of Advanced-Stage HCC

Rahul Gosain, MD;Rohit Gosain, MD;Tanios S. Bekaii-Saab, MD, FACP
April 1st 2024

Turning the focus to advanced-stage HCC, Tanios S. Bekaii-Saab, MD, offers comprehensive insights on first- and second-line treatment options.


Tanios S. Bekaii-Saab, MD, and the Oncology Brothers presenting slides

EP. 4: Treating HCC: Safety Profile Considerations

Rahul Gosain, MD;Rohit Gosain, MD;Tanios S. Bekaii-Saab, MD, FACP
April 1st 2024

Tanios S. Bekaii-Saab, MD, discusses safety profile considerations for patients undergoing treatment for hepatocellular carcinoma, and the Oncology Brothers recap the entire discussion.

Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.